Lutonix: Back To The Future With Drug-Coated Balloons

01 Sep 2011

Drug-coated balloons were once thought to be an unnecessary innovation because of drug-eluting stents. With DES no longer seen as the panacea for vascular disease, balloons could re-emerge as the next major technology platform, and Lutonix is leading the race to bring them to the US market.

By Stephen Levin

During the peak of the drug-eluting stent (DES) wave in the early to mid 2000s, cardiovascular conferences actually entertained discussions...